Results 151 to 160 of about 1,671 (202)

The impact of antithrombin III supplementation on prognosis during extracorporeal membrane oxygenation: a systematic review and meta-analysis. [PDF]

Ann Med
Zeng YT, Liu YN, Chen ZH, Chen Q, Sun KP.   +4 more
europepmc   +1 more source

BMI differences on anticoagulation with bivalirudin vs. heparin during primary PCI: a BRIGHT-4 subanalysis. [PDF]

BMC Med
Zhang D, Li Y, Qiu M, Liang Z, Xu K, Li Y, Zhang G, Xie W, Zeng H, Cheng Y, Liu J, Cheng X, Zeng Q, Zhu K, Hu J, Cheng K, Wang J, Cheng R, Zhou Y, Wang B, Cao G, Han Y, Stone GW.   +22 more
europepmc   +1 more source

A single-dose, four-cycle, fully repetitive crossover bioequivalence of dabigatran etexilate in Chinese. [PDF]

BMC Pharmacol Toxicol
Yang Z, Li Q, Yu D, Zhang X, Wang Y, Liu S, Chen L, Zhou Y, Zeng C, Zeng Y, Cai C, Xiong Y, Zhang Q, Li N, Du P, Liu L, Chen J, He Y.   +17 more
europepmc   +1 more source

The efficacy and safety of bivalirudin and heparin in patients with acute coronary syndrome: a systematic review and meta-analysis. [PDF]

Syst Rev
Zhai Y, Shang H, Li Y, Zhang N, Zhang J, Wu S.   +5 more
europepmc   +1 more source

Prior Anticoagulation and Risk of Hemorrhagic Transformation in Acute Stroke: A Post Hoc Analysis of the PRODAST Study. [PDF]

J Am Heart Assoc
Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Grond M, Rollnik JD, Marquardt L, Kraft A, Schlemm E, Eggers C, Eschenfelder CC, Weimar C, Diener HC.   +13 more
europepmc   +1 more source

Dabigatran Attenuates the Binding of Thrombin to Platelets-A Novel Mechanism of Action. [PDF]

Thromb Haemost
Lindahl TL, Kumar AP, Hallström T, Al-Hashimi A, du Rietz A, Arlaman E, Uvdal K, Macwan AS.   +7 more
europepmc   +1 more source

Importance of infarct topography in determination of stroke mechanism and recurrence risk: a post-hoc analysis of the dabigatran acute treatment of stroke trial. [PDF]

BMJ Open
Cimen E, Ng K, Buck BH, Field T, Coutts SB, Gioia LC, Hill MD, Miller J, Benavente OR, Sharma M, Butcher K.   +10 more
europepmc   +1 more source

The role of antithrombin in venous and arterial thrombosis [PDF]

, 2018
Croles, Nanne
core  

Some of the next articles are maybe not open access.

Related searches:

Antithrombin

2013
Antithrombin (AT) is a heparin cofactor and a member of the serine protease inhibitor family (serpin). The mature AT molecule is composed of 432 amino acids and it is produced mainly in the liver. Initially, several different AT activities in plasma were reported, leading to the classification of antithrombin in a range from I to IV.
Mirta, Hepner, Vasiliki, Karlaftis
openaire   +2 more sources

Antiangiogenic Antithrombin

Seminars in Thrombosis and Hemostasis, 2007
Angiogenesis is critical for several physiologic and pathophysiologic processes, and several angiogenesis inhibitors are now in clinical trials for the treatment of cancer. Antithrombin is a member of the serpin family of proteins and functions as an inhibitor of thrombin and other enzymes involved in the clotting cascade. While studying the inhibition
openaire   +2 more sources